Know Cancer

or
forgot password

Activating Collaborative CIS Support Via Targeted Provider Mailing


N/A
18 Years
N/A
Open (Enrolling)
Female
Precancerous Condition

Thank you

Trial Information

Activating Collaborative CIS Support Via Targeted Provider Mailing


OBJECTIVES:

- Compare the effect of a usual care mailing intervention vs a Cancer Information Service
(CIS) support mailing intervention on the likelihood that women with an abnormal Pap
test will keep their medical follow-up appointments and be satisfied with how they talk
to their provider.

OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 intervention arms.

- Arm I (Usual-care mailing intervention): Patients receive a generic letter reminding
them of their follow-up colposcopy appointment.

- Arm II (Cancer Information Service [CIS] support mailing intervention): Patients
receive a targeted letter reminding them of their follow-up colposcopy appointment,
asking them or someone they designate to call the CIS, and suggesting some questions to
ask the CIS about colposcopies and Pap tests.

At their follow-up appointments, all patients undergo an exit interview to compare patient
satisfaction between the 2 interventions. Patients in arm II also answer questions about
their CIS experience, and if the intervention made their follow-up visit less difficult.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Received an abnormal Pap test result

- Scheduled for a colposcopy within 6 months of their Pap test at either the Erie
Family Health Center or the Prentice Ambulatory Clinic

PATIENT CHARACTERISTICS:

- Able to communicate in either English or Spanish

- Clinic staff will review patient charts to determine eligibility

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Primary Purpose: Health Services Research

Outcome Measure:

Patient satisfaction in the 2 interventions

Safety Issue:

No

Principal Investigator

Bonnie Spring, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Robert H. Lurie Cancer Center

Authority:

Unspecified

Study ID:

CDR0000626557

NCT ID:

NCT00873288

Start Date:

October 2006

Completion Date:

Related Keywords:

  • Precancerous Condition
  • cervical intraepithelial neoplasia
  • atypical squamous cells of undetermined significance
  • high-grade squamous intraepithelial lesion
  • low-grade squamous intraepithelial lesion
  • Precancerous Conditions

Name

Location

Robert H. Lurie Comprehensive Cancer Center at Northwestern UniversityChicago, Illinois  60611
Erie Family Health CenterChicago, Illinois  60622